114 related articles for article (PubMed ID: 1926582)
41. Reexamination of the extent of the activation of Lys78 plasminogen by tissue plasminogen activator in the presence of polymerized fibrin.
Urano T; Takada Y; Ihara H; Takada A
Haemostasis; 1996; 26(4):220-7. PubMed ID: 8872134
[TBL] [Abstract][Full Text] [Related]
42. Fibrinogen lysine residue A alpha 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator.
Voskuilen M; Vermond A; Veeneman GH; van Boom JH; Klasen EA; Zegers ND; Nieuwenhuizen W
J Biol Chem; 1987 May; 262(13):5944-6. PubMed ID: 3106345
[TBL] [Abstract][Full Text] [Related]
43. Kinetic studies of plasminogen activation by epithelial tissue plasminogen activator.
Electricwala A; Ling RJ; Atkinson T
Blood Coagul Fibrinolysis; 1990; 1(1):31-9. PubMed ID: 2129390
[TBL] [Abstract][Full Text] [Related]
44. Nonclottable fibrin obtained from partially reduced fibrinogen: characterization and tissue plasminogen activator stimulation.
Procyk R; Medved L; Engelke KJ; Kudryk B; Blombäck B
Biochemistry; 1992 Mar; 31(8):2273-8. PubMed ID: 1540582
[TBL] [Abstract][Full Text] [Related]
45. Studies on the localization and accessibility of sites in fibrin which are involved in the acceleration of the activation of plasminogen by tissue-type plasminogen activator.
Nieuwenhuizen W; Schielen WJ; Yonekawa O; Tesser GI; Voskuilen M
Adv Exp Med Biol; 1990; 281():83-91. PubMed ID: 2129380
[No Abstract] [Full Text] [Related]
46. Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation.
Nieuwenhuizen W
Thromb Res; 1994 Aug; 75(3):343-7. PubMed ID: 7992246
[TBL] [Abstract][Full Text] [Related]
47. Elimination of the Cys558-Cys566 bond in Lys78-plasminogen--effect on activation and fibrin interaction.
Linde V; Nielsen LS; Foster DC; Petersen LC
Eur J Biochem; 1998 Jan; 251(1-2):472-9. PubMed ID: 9492320
[TBL] [Abstract][Full Text] [Related]
48. Location of plasminogen-binding sites in human fibrin(ogen).
Váradi A; Patthy L
Biochemistry; 1983 May; 22(10):2440-6. PubMed ID: 6222763
[TBL] [Abstract][Full Text] [Related]
49. The effect of fibrinogen polymerization and crosslinking on exposure of fibrin-specific epitopes and t-PA mediated plasminogen activation.
Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
Ukr Biokhim Zh (1978); 1996; 68(4):37-8. PubMed ID: 9226823
[No Abstract] [Full Text] [Related]
50. Monoclonal antibody enhances plasminogen activation by t-PA.
Matsuo O; Okada K; Fukao H; Ueshima S
Thromb Res; 1989 Nov; 56(3):477-83. PubMed ID: 2515613
[No Abstract] [Full Text] [Related]
51. Species specificity in the acceleration of tissue-type plasminogen activator-mediated activation of plasminogens, by fibrinogen cyanogen bromide fragments.
Nieuwenhuizen W; Keyser J
Thromb Res; 1985 Jun; 38(6):663-70. PubMed ID: 4040660
[TBL] [Abstract][Full Text] [Related]
52. Degradation of the alpha-chain of fibrin by human neutrophil elastase reduces the stimulating effect of fibrin on plasminogen activation.
Bach-Gansmo ET; Halvorsen S; Godal HC; Skjønsberg OH
Thromb Res; 1994 Aug; 75(3):307-17. PubMed ID: 7992241
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator bm 06.022 in healthy volunteers.
Martin U; von Möllendorff E; Akpan W; Kientsch-Engel R; Kaufmann B; Neugebauer G
Thromb Haemost; 1991 Nov; 66(5):569-74. PubMed ID: 1725068
[TBL] [Abstract][Full Text] [Related]
54. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
Hoylaerts M; Rijken DC; Lijnen HR; Collen D
J Biol Chem; 1982 Mar; 257(6):2912-9. PubMed ID: 7199524
[TBL] [Abstract][Full Text] [Related]
55. Regulation of plasminogen activation by components of the extracellular matrix.
Stack S; Gonzalez-Gronow M; Pizzo SV
Biochemistry; 1990 May; 29(20):4966-70. PubMed ID: 2114170
[TBL] [Abstract][Full Text] [Related]
56. Localization in the fibrinogen gamma-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen.
Yonekawa O; Voskuilen M; Nieuwenhuizen W
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):187-91. PubMed ID: 1567367
[TBL] [Abstract][Full Text] [Related]
57. Importance of intramolecular interactions in the control of the fibrin affinity and activation of human plasminogen.
Bányai L; Patthy L
J Biol Chem; 1984 May; 259(10):6466-71. PubMed ID: 6725259
[TBL] [Abstract][Full Text] [Related]
58. A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I.
Niwa K; Takebe M; Sugo T; Kawata Y; Mimuro J; Asakura S; Sakata Y; Mizushima J; Maeda A; Endo H; Matsuda M
Blood; 1996 Jun; 87(11):4686-94. PubMed ID: 8639838
[TBL] [Abstract][Full Text] [Related]
59. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.
Mori K; Dwek RA; Downing AK; Opdenakker G; Rudd PM
J Biol Chem; 1995 Feb; 270(7):3261-7. PubMed ID: 7852411
[TBL] [Abstract][Full Text] [Related]
60. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.
Zamarron C; Lijnen HR; Collen D
J Biol Chem; 1984 Feb; 259(4):2080-3. PubMed ID: 6538196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
